UPS to Invest $48 Million Expanding Healthcare Network With Temperature-Controlled Facilities

Dow Jones06-22 22:51

By Connor Hart

 

United Parcel Service said it will invest $48 million to build 27 temperature-controlled freight cross-dock facilities across the globe, strengthening its healthcare network as demand for temperature-sensitive medicines grows.

The new facilities will be located in key domestic and international markets including Europe, Asia and the Americas, the company said Monday.

"We have aligned our investments with our Healthcare customers' specialized needs," said Kate Gutmann, president of international healthcare and supply chain solutions. "Our global cross-dock facilities strengthen our end-to-end cold-chain capabilities to ensure critical treatments are delivered safely and reliably to patients around the world."

Healthcare supply chains are becoming more complex and risk-sensitive as therapies including cell and gene treatments, mRNA platforms and GLP-1 injectables come to market, UPS said. That's because many of these medicines require strict temperate ranges of 2 to 8 degrees Celsius, 15 to 25 degrees Celsius, and frozen.

UPS's latest investment in its healthcare network builds on the company's long-term investments in complex healthcare logistics, including recent acquisitions such as Bomi Group in Europe and Andlauer Healthcare Group in North America.

 

Write to Connor Hart at connor.hart@wsj.com

 

(END) Dow Jones Newswires

June 22, 2026 10:51 ET (14:51 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment